Also Read: Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks ... testimony that Zantac could cause cancer, as a federal judge did in 2022 for about 50,000 claims in Florida.

"Judge Medinilla resoundingly rejected GSK ... introducing expert testimony that Zantac can cause cancer, as a federal judge did in 2022 in about 50,000 claims centralized in Florida.

Hung jury in latest Zantac cancer trial in Chicago Boehringer Ingelheim only defendant after settlements with GSK, Pfizer FDA pulled Zantac in 2020 over NDMA carcinogen concerns Sept 18 (Reuters ...

Although GSK has consented to the settlement, the firm has rejected any admission of guilt, citing an absence of "consistent or reliable evidence" connecting Zantac to cancer. Additionally ...

Pfizer Inc. and other drugmakers to overturn a judge who allowed more than 80,000 lawsuits to proceed to trial over claims that the heartburn drug Zantac is linked to cancer. The state’s highest ...

The plaintiffs claim that they developed cancer due to the medication Zantac, which is used to relieve ... jurisdiction for "innovator liability" claims, but this is "a theory of liability that ...

The crux of her argument and the claims made in the other suits is that the active ingredient in Zantac, called ranitidine, degrades into the cancer-causing substance NDMA, or nitrosodimethylamine.

If the state high court rejects the appeal, the Zantac lawsuits will ... that Zantac could cause cancer, as a federal judge did in 2022 for about 50,000 claims in Florida. These lawsuits depend ...

"Judge Medinilla resoundingly rejected GSK, Boehringer Ingelheim ... the plaintiffs from introducing expert testimony that Zantac can cause cancer, as a federal judge did in 2022 in about 50,000 ...